Back to MW Marshall Wace, LLP
PRAX
Showing 7 of 10 quarters
Position history for MWMarshall Wace, LLP's holdings in Praxis Precision Medicines, Inc.
Yes. Marshall Wace holds 137,008 shares of PRAX (Praxis Precision Medicines), worth $45.9M, as of its Q2 2026 13F filing. It increased the position from 45,149 shares in Q1 2026. Marshall Wace has held PRAX since Q3 2025, across 4 quarterly 13F filings.
Current Value
$45.9M
Current Shares
137,008
Total Value Change
+$36.1M
Total Shares Change
-33,087
Quarter-by-Quarter History